Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study of High - Flux Plasma Diafiltration Based on Plasma - Saved Mode in the Treatment of Patients With Hepatic Failure

NCT03560414 is registered in ClinicalTrials.gov with Fuzhou General Hospital as lead sponsor.

NCT NCT03560414
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03560414 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study of High - Flux Plasma Diafiltration Based on Plasma - Saved Mode in the Treatment of Patients With Hepatic Failure
Lead sponsor
Fuzhou General Hospital
Phase
Not applicable
Overall status
Unknown status
Start date
June 30, 2018
Completion date
December 31, 2020
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hepatic failure, plasma exchange